Winslow Garrett
General Counsel
Winslow Garrett has filed 2 SEC Form 4 filings (4 transaction rows) across 2 companies, including DMRA, GLTO, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Jul 8, 2026.
On the most recent filing, Winslow Garrett is listed as General Counsel at Damora Therapeutics, Inc. Inside the rolling window, Winslow Garrett reported no open-market purchases and 2 open-market sales totaling $13K in DMRA and GLTO. The largest disclosed transaction in the window is a sale of 245 DMRA shares on Jul 6, 2026, worth $7K.
Companies traded
Other insiders at DMRA
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$13K
reported sales (SEC code S)
Companies
2
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Winslow Garrett made?
Winslow Garrett has filed 2 SEC Form 4 filings (4 transaction rows) across 2 companies, including DMRA, GLTO since 2026.
Which companies does Winslow Garrett trade?
Winslow Garrett has filed SEC Form 4 disclosures for 2 companies, including DMRA, GLTO.
When was Winslow Garrett's most recent SEC Form 4 filing?
Winslow Garrett's most recent SEC Form 4 filing on Tracefour is dated Jul 8, 2026.
What is Winslow Garrett's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Winslow Garrett is listed as General Counsel.
What is Winslow Garrett's total buy and sell value in the current window?
Inside the rolling retention window, Winslow Garrett bought $0 and sold $13K based on SEC Form 4 filings.
What was Winslow Garrett's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 245 DMRA shares on 2026-07-06, worth $7K, per SEC Form 4 filings.